Lung Cancer clinical trials in Mississippi

10 actively recruiting lung cancer trials at 12 sites across Mississippi.

Data from ClinicalTrials.gov · last refreshed 2026-09-07

Phase 3 Recruiting NIH

Immunotherapy After Surgery for People Who Have No Remaining Cancer Cells After Standard Treatment for Early-Stage Non-Small Cell Lung Cancer, INSIGHT Trial

This phase III trial compares durvalumab to the usual approach (patient observation) after surgery for the treatment of patients with early-stage non-small cell lung cancer. Immunotherapy with monoclonal antibodies, such as durvalumab, may…

Sponsor: National Cancer Institute (NCI)

NCT ID: NCT06498635

Sites in Mississippi:

Baptist Memorial Hospital and Cancer Center-Golden Triangle — Columbus, Mississippi
Baptist Cancer Center-Grenada — Grenada, Mississippi
University of Mississippi Medical Center — Jackson, Mississippi
Baptist Memorial Hospital and Cancer Center-Union County — New Albany, Mississippi
Baptist Memorial Hospital and Cancer Center-Oxford — Oxford, Mississippi

View on ClinicalTrials.gov →

Phase 3 Recruiting Academic/Other

Testing Longer Duration Radiation Therapy Versus the Usual Radiation Therapy in Patients With Cancer That Has Spread to the Brain

This phase III trial compares the effectiveness of fractionated stereotactic radiosurgery (FSRS) to usual care stereotactic radiosurgery (SRS) in treating patients with cancer that has spread from where it first started to the brain. Radia…

Sponsor: NRG Oncology

NCT ID: NCT06500455

Sites in Mississippi:

University of Mississippi Medical Center — Jackson, Mississippi

View on ClinicalTrials.gov →

Phase 2, Phase 3 Recruiting Industry

Phase 2 Trial of Adagrasib Monotherapy and in Combination With Pembrolizumab and a Phase 3 Trial of Adagrasib in Combination in Patients With a KRAS G12C Mutation KRYSTAL-7

The Phase 2 portion of this study evaluates the efficacy and safety of MRTX849 monotherapy and in combination with pembrolizumab in cohorts of patients with advanced NSCLC with KRAS G12C mutation and any PD-L1 TPS and who are candidates fo…

Sponsor: Mirati Therapeutics Inc.

NCT ID: NCT04613596

Sites in Mississippi:

Jackson Oncology Associates - The Hederman Cancer Center — Jackson, Mississippi

View on ClinicalTrials.gov →

Phase 3 Recruiting Industry

Symbiotic-Lung-01 : A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Locally Advanced or Metastatic Non-Small Cell Lung Cancer

This study is being done to find out if a new medicine called PF-08634404, when given with chemotherapy, works better than the present standard treatment (pembrolizumab with chemotherapy) for adults with a type of lung cancer called non-sm…

Sponsor: Pfizer

NCT ID: NCT07222566

Sites in Mississippi:

Hattiesburg Clinic Hematology/Oncology — Hattiesburg, Mississippi

View on ClinicalTrials.gov →

Phase 3 Recruiting Industry

This is a Study to Learn About How the Combination of the Study Medicines Sigvotatug Vedotin Plus Pembrolizumab Works in People With Non-small Cell Lung Cancer With High Levels of PD-L1.

The purpose of the study is to compare how the new combination treatment (Sigvotatug Vedotin plus pembrolizumab) works compared to pembrolizumab alone in patients with non-small cell lung cancer (NSCLC) with high levels of PD-L1. This is a…

Sponsor: Pfizer

NCT ID: NCT06758401

Sites in Mississippi:

Jackson Oncology Associates, PLLC — Jackson, Mississippi
Jackson Oncology Associates, PLLC — Jackson, Mississippi

View on ClinicalTrials.gov →

Phase 3 Recruiting Industry

A Study to Compare the Efficacy of Nivolumab and Relatlimab Plus Chemotherapy vs Pembrolizumab Plus Chemotherapy for Stage IV/Recurrent Non-squamous Non-small Cell Lung Cancer With PD-L1 Expression ≥ 1%

The purpose of this study is to compare the efficacy of Nivolumab and Relatlimab in combination with chemotherapy to Pembrolizumab with Chemotherapy in participants with stage IV or recurrent Non-squamous Non-small Cell Lung Cancer with PD…

Sponsor: Bristol-Myers Squibb

NCT ID: NCT06561386

Sites in Mississippi:

Hattiesburg Clinic Hematology/Oncology — Hattiesburg, Mississippi

View on ClinicalTrials.gov →

Phase 3 Recruiting Industry

A Study Comparing Tarlatamab, Durvalumab, Carboplatin, and Etoposide Versus Durvalumab, Carboplatin, and Etoposide in First-line Extensive Stage Small-Cell Lung Cancer (ES-SCLC)

The main objective of the study is to compare the efficacy of tarlatamab in combination with durvalumab, carboplatin and etoposide to the combination of durvalumab, carboplatin and etoposide on prolonging overall survival (OS).

Sponsor: Amgen

NCT ID: NCT07005128

Sites in Mississippi:

Hattiesburg Clinic Hematology/Oncology — Hattiesburg, Mississippi

View on ClinicalTrials.gov →

Recruiting Academic/Other

Assessing Benefits and Harms of Cannabis/Cannabinoid Use Among Cancer Patients Treated in Community Oncology Clinics

This is a multi-site clinical study enrolling 2000 newly diagnosed patients with breast, colorectal, melanoma, non-Hodgkin lymphoma, or non-small cell lung cancer, who are planning to receive one or more systemic cancer directed therapies …

Sponsor: Wake Forest University Health Sciences

NCT ID: NCT06418204

Sites in Mississippi:

Baptist Memorial Hospital and Cancer Center-Golden Triangle — Columbus, Mississippi
Baptist Cancer Center-Grenada — Grenada, Mississippi
Baptist Memorial Hospital and Cancer Center-Union County — New Albany, Mississippi
Baptist Memorial Hospital and Cancer Center-Oxford — Oxford, Mississippi
Baptist Memorial Hospital and Cancer Center-Desoto — Southaven, Mississippi

View on ClinicalTrials.gov →

Recruiting Academic/Other

Prospective Non-Interventional Study Comparing Osimertinib +/- Chemotherapy for EGFR-Mutated NSCLC Patients

The goal of the study is to collect data on patients treated outside of a clinical trial (in routine clinical practice) with standard of care osimertinib with or without chemotherapy in Epidermal Growth Factor Receptor (EGFR)-mutant Non-Sm…

Sponsor: PrECOG, LLC.

NCT ID: NCT06538038

Sites in Mississippi:

Baptist Memorial Hospital and Cancer Center - Golden Triangle — Columbus, Mississippi
Baptist Cancer Center - Grenada — Grenada, Mississippi
Jackson Oncology Associates PLLC — Jackson, Mississippi
Mississippi Baptist Medical Center — Jackson, Mississippi
Baptist Memorial Hospital and Cancer Center - Union — New Albany, Mississippi

View on ClinicalTrials.gov →

NA Recruiting Academic/Other

Statewide Optimization of Lung Cancer Screening Utilizing the QUILS™ System in Nevada and Mississippi: State-Based Initiative Component

This clinical trial studies whether a Quality Implementation of Lung Cancer Screening (QUILS™) System state-based initiative (SBI) intervention works to improve the statewide capacity for implementing and sustaining lung cancer screening i…

Sponsor: Timothy Mullett

NCT ID: NCT07682597

Sites in Mississippi:

Delta Health System — Greenville, Mississippi
Greenwood Leflore Hospital — Greenwood, Mississippi
Memorial Hospital Gulfport — Gulfport, Mississippi
Hattiesburg Clinic — Hattiesburg, Mississippi
University of Mississippi Medical Center — Jackson, Mississippi

View on ClinicalTrials.gov →

Medical disclaimer: This page aggregates public ClinicalTrials.gov data. It is not medical advice. Always confirm eligibility and enrollment details with the trial site or your oncologist.

Source: ClinicalTrials.gov API v2 · Last checked: 2026-09-07